Samuel H. Whiting
- Co-authors
- James J. ChampouxVikas GoelTerry KatzStanley R. RiddellWei XiongVenu G. PillarisettyCassian YeeJonathan G. Sham
- Topics
- Pancreatic and Hepatic Oncology Research (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)HIV Research and Treatment (3 papers)
- Cited by
- VirologyOncologyCancer Research
- Partner nations
- United StatesBulgariaCanada
In The Last Decade
Samuel H. Whiting
18 papers receiving 422 citations
Peers
Comparison fields: 5 of 58
- Oncology 203
- Molecular Biology 176
- Immunology 79
- Virology 74
- Cancer Research 73
Countries citing papers authored by Samuel H. Whiting
This map shows the geographic impact of Samuel H. Whiting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel H. Whiting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel H. Whiting more than expected).
Fields of papers citing papers by Samuel H. Whiting
This network shows the impact of papers produced by Samuel H. Whiting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel H. Whiting. The network helps show where Samuel H. Whiting may publish in the future.
Co-authorship network of co-authors of Samuel H. Whiting
This figure shows the co-authorship network connecting the top 25 collaborators of Samuel H. Whiting. A scholar is included among the top collaborators of Samuel H. Whiting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel H. Whiting. Samuel H. Whiting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 20 | |
| 3 | 17 | |
| 4 | 1 | |
| 5 | 99 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 25 | |
| 11 | 13 | |
| 12 | 18 | |
| 13 | A phase I study of the recombinant human IgG1 anti-IGF-IR monoclonal antibody (Mab) IMC-A12, administered on a weekly basis to patients with advanced solid tumors: Interim analysis | 9 |
| 14 | 71 | |
| 15 | 42 | |
| 16 | 20 | |
| 17 | 43 | |
| 18 | 14 |
About Samuel H. Whiting
Samuel H. Whiting is a scholar working on Virology, Cancer Research and Oncology, having authored 18 papers that have together received 435 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Virology (74 citations), Oncology (203 citations) and Cancer Research (73 citations). Samuel H. Whiting has collaborated with scholars based in United States, Bulgaria and Canada. Frequent co-authors include James J. Champoux, Vikas Goel, Terry Katz, Stanley R. Riddell, Wei Xiong, Venu G. Pillarisetty, Cassian Yee, Jonathan G. Sham, Kendall C. Shibuya and Floyd E. Fox. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.